Prestige Consumer Healthcare (PBH) Share-based Compensation (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Share-based Compensation of $2.7 million in Q4 2025, up 55.01% quarter-over-quarter from $1.8 million in Q3 2025, and down 4.4% on a YoY basis from $2.9 million in Q4 2024.
Prestige Consumer Healthcare (PBH) Share-based Compensation (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Share-based Compensation history runs 16 years deep, the most recent figure standing at $2.7 million for Q4 2025.
- In Q4 2025, Share-based Compensation fell 4.4% year-over-year to $2.7 million; the TTM figure through Dec 2025 stood at $10.9 million (down 10.12% YoY), while the FY2025 annual figure was $11.2 million, down 20.36% from the prior year.
- Share-based Compensation was $2.7 million for Q4 2025 at Prestige Consumer Healthcare, up from $1.8 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $4.1 million in Q2 2023 to a low of $1.7 million in Q1 2022.
- Historically, Share-based Compensation has averaged $2.9 million across 5 years, with a median of $2.7 million in 2025.
- The sharpest annual moves came in 2022 and 2024: Share-based Compensation soared 105.38% in 2022, then sank 42.14% in 2024.
- A 5-year view of Share-based Compensation shows it stood at $2.2 million in 2021, then rose by 8.91% to $2.4 million in 2022, then rose by 0.66% to $2.4 million in 2023, then increased by 16.99% to $2.9 million in 2024, then dropped by 4.4% to $2.7 million in 2025.
- The last three Share-based Compensation figures came in at $2.7 million (Q4 2025), $1.8 million (Q3 2025), and $3.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 36.86 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.04 Mn |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | 2.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.74 Mn |
| Dec 31, 2025 | 2.74 Mn |
| Sep 30, 2025 | 1.77 Mn |
| Sep 30, 2025 | 1.77 Mn |
| Jun 30, 2025 | 3.68 Mn |
| Jun 30, 2025 | 3.68 Mn |
| Mar 31, 2025 | 2.73 Mn |
| Mar 31, 2025 | 2.73 Mn |
| Dec 31, 2024 | 2.87 Mn |
| Dec 31, 2024 | 2.87 Mn |
| Sep 30, 2024 | 2.13 Mn |
| Sep 30, 2024 | 2.13 Mn |
| Jun 30, 2024 | 3.43 Mn |
| Jun 30, 2024 | 3.43 Mn |
| Mar 31, 2024 | 3.73 Mn |
| Mar 31, 2024 | 3.73 Mn |
| Dec 31, 2023 | 2.45 Mn |
| Dec 31, 2023 | 2.45 Mn |
| Sep 30, 2023 | 3.69 Mn |
| Sep 30, 2023 | 3.69 Mn |